3 ms·
> where people need access to leading-edge potential treatments' Those leading edge potential treatments tend to be both very expensive and ineffective, and o
by DanBC 8y ago
> where people need access to leading-edge potential treatments'
Those leading edge potential treatments tend to be both very expensive and ineffective, and often cause additional harm on top.
That's from the analysis of a leading oncologist in the UK.
https://www.bmj.com/content/357/bmj.j2097 https://www.bmj.com/content/357/bmj.j2097
- conanbatt 8y agoI'm not making a judgement on the clinical validity of experimental treatments. That was a direct quote from the article.